2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Monday, September 23, 2019

1:45pm-3:15pm: Hemifacial spasm management: 26-year experience

Y. Herrero-Infante, A. Rodriguez-Sanz, J. Mañez-Miró, F. Vivancos-Matellano (Madrid, Spain)

Other · Agora 2 West, Level 2

1:45pm-3:15pm: Hereditary and geneological aspects of Parkinson’s disease and essential tremor in people of Uzbek nationality

R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Heterozygous DCC mutations, more than congenital mirror movements

S. Thams, M. Islam, M. Lindefeldt, A. Nordgren, T. Granberg, D. Nilsson, M. Paucar (Stockholm, Sweden)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: HGprt deficiency affects early brain development in vivo in a mouse model of Lesch-Nyhan disease

J. Witteveen, S. Loopstok, L. Luque Ballesteros, A. Boonstra, N. van Bakel, W. van Boekel, G. Martens, J. Visser, S. Kolk (Nijmegen, Netherlands)

Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3

1:45pm-3:15pm: HGprt deficient brain RNA expression patterns reveal specific abnormalities related to neuronal function in a mouse model of Lesch-Nyhan disease.

J. Visser, C. Klemann, G. Martens (Nijmegen, Netherlands)

Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3

1:45pm-3:15pm: High Content Screening of synucleinopathy in primary cortical neurons : dissecting out the interplay between the basic synuclein pools

F. de Giorgi, E. Bezard, F. Ichas (Bordeaux, France)

Other · Agora 2 West, Level 2

1:45pm-3:15pm: High Dose Botulinum Toxin Therapy: Safety, Benefit and Endurance of Efficacy

S. Chiu, B. Patel, M. Burns, J. Legacy, A. Shukla, A. Ramirez-Zamora, W. Deeb, I. Malaty (Gainesville, FL, USA)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: High dose off-label Safinamide treatment in Young Onset Parkinson’s Disease patients

C. Carrarini, M. Russo, F. Barbone, F. Dono, M. Rispoli, M. Onofrj, A. Thomas (Chieti, Italy)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: High rate of mutations in complex dystonia revealed by exome sequencing

T. Wirth, C. Tranchant, N. Drouot, B. Keren, L. Cif, C. Mignot, R. Lefaucheur, L. Lion-François, A. Méneret, D. Gras, E. Flamand-Roze, C. Laroche, P. Burbaud, S. Bannier, O. Boukbiza, MA. Spitz, V. Laugel, M. Bereau, D. Doummar, G. Rudolf, M. Anheim, J. Chelly (Illkirch-Graffenstaden, France)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Hippotherapy for axial symptoms, gait and posture in people with Parkinson disease: A case report

T. Mcisaac, J. Hayes, J. Goodman, O. Harpham, N. Erickson (Mesa, AZ, USA)

Physical and Occupational Therapy · Les Muses Terrace, Level 3